Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities
Molecular and Cellular Neuroscience · 2026
DOI: 10.1016/j.mcn.2026.104108 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular and Cellular Neuroscience, 2026. Verfasst von Saravanan Jayaram und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, 643 001, Tamil Nadu, India. Elec…. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoproteins E, Signal Transduction, Receptors, LDL. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 194 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Apolipoprotein E, a glycoprotein, is one of the strongest genetic risk factors for late-onset Alzheimer's disease. APOE is involved in the transport and metabolism of cholesterol, phospholipids and other lipids, synaptic function and neuroinflammation in the CNS. One of the key functions of APOE is to bind and deliver newly synthesized cholesterol and lipids to neurons through receptor-mediated endocytosis (LDLR, LRP1, VLDLR, APOER2). The APOE gene exists in three common isoforms: APOE2, APOE3, and APOE4, with distinct structural and functional properties. The three isoforms of APOE vary in their potential to bind and transport lipids and cholesterol, receptor affinity and clearance of Aβ. Among the three isoforms, APOE4 is one of the strongest risk factors for late-onset Alzheimer's disease, while APOE2 exerts a protective role highlighting the functional divergence among isoforms in CNS physiology. The functions of APOE are exerted through binding of APOE with members of the low-density lipoprotein receptor (LDLR) family, including LDLR, LRP1, VLDLR, and APOER2. So, approaches that potentiate the protective effects of APOE, like APOE mimetics, ABCA1 agonists, targeting APOE receptors like LDLR, LRP1, APOER2, and TREM2, might offer significant therapeutic benefits in Alzheimer's disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris, 643 001, Tamil Nadu, India. Electronic address: saravananjayaram@jssuni.edu.in.
- Department of Clinical Pharmacy, King Khalid University, Abha, Kingdom of Saudi Arabia.
- Department of Pharmacology, Prime College of Pharmacy, Palakkad, Kerala, India.
- Department of Pharmacology, PSG College of Pharmacy, Coimbatore, India.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research, SRMC(DU) Porur, Chennai, India.
- Department of CLT, Dr. NGP Arts and Science College, Coimbatore, India.
Zitieren
APA
Jayaram, S., Easwaran, V., Selvaraj, D., Gunasekaran, V., Soumya, V., Thiruselvi, M., Laxmana Prasanth, M., Singh, S., Ellaiyarasu, C., Karthik Rai, P., Gokula Priyan, G., Thahideen, A., & Sabarieshwaran, K. (2026). Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities. Molecular and Cellular Neuroscience. https://doi.org/10.1016/j.mcn.2026.104108
Vancouver
Jayaram S, Easwaran V, Selvaraj D, Gunasekaran V, Soumya V, Thiruselvi M, et al. Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities. Molecular and Cellular Neuroscience. 2026. doi:10.1016/j.mcn.2026.104108
BibTeX
@article{Jayaram2026,
author = {Jayaram, Saravanan and Easwaran, Vigneshwaran and Selvaraj, Divakar and Gunasekaran, Venkatesh and Soumya, V and Thiruselvi, M and Laxmana Prasanth, M and Singh, Siddharth and Ellaiyarasu, C and Karthik Rai, P and Gokula Priyan, G and Thahideen, A and Sabarieshwaran, K},
title = {Apolipoprotein E in Alzheimer's disease: A review of APOE receptors, signalling pathways and therapeutic opportunities},
journal = {Molecular and Cellular Neuroscience},
year = {2026},
doi = {10.1016/j.mcn.2026.104108}
}
EUVIMED